The Innovative Medicines Initiative (IMI2)
27 July 2018

The Innovative Medicines Initiative (IMI2)

QSAR Lab is a part of a consortium that has applied for European grant in the Innovative Medicines Initiative (IMI2). Our proposal competes in the IMI2-Call 14 (H2020-JTI-IMI2-2018-14), in the topic number 3 entitled “Development of a platform for federated and privacy-preserving machine learning in support of drug discovery”. The call is funded jointly by the European Union (represented by the European Commission) and the European pharmaceutical industry (represented by EFPIA, the European Federation of Pharmaceutical Industries and Associations).
We will inform about the results after a summer break.

The source of the picture is https://www.imi.europa.eu/


This site uses cookies read more   OK. I understand